(ages ranged from 23 to 39 years). NK activity against K562 cells was determined by both 51Cr release assays and singlecell assays. Data are presented as the mean + SD of at least four independent experiments. Statistical analyses were performed by Student's t test with the program Tadpole III. Table 1 shows the NK activities of 13 KA patients and 10 normal individuals determined by 4-h 51Cr release assays with an effector cell/target cell (E/T) ratio of 50:1. 51Cr release assays were performed as described previously (3) . Briefly, freshly passaged K562 targets were labeled with Na251CrO4 (Bhabha Atomic Research Centre, Bombay, India). Radiolabeled target cells (5 x 103) in 0.1 ml of RPMI 1640 medium containing 10% fetal bovine serum and various concentrations of effector cells (PBMC) in 0.1-ml aliquots were added to round-bottom microtiter wells (GIBCO Laboratories) to yield the desired E/T ratios. All determinations were done in triplicate. Plates were incubated for 4 and 18 h at 37?C in 5% CO2. After incubation, 0.1-ml supernatants were collected from each well without disturbing the cell pellet and their radioactivity was counted in a gamma counter. The percent 51Cr release was calculated by the following formula: % 51Cr release = 100 x [(cpm experimental -cpm spontaneous)/(cpm total -cpm spontaneous)], where spontaneous release was that obtained from target cells incubated with medium alone, total release was that obtained from target cells incubated with 1 N HCl, and cpm is counts per minute. In 4-h assays, spontaneous release never exceeded 12% of the total release, while in 18-h assays, spontaneous release never exceeded 30%.
Both freshly isolated and overnight cultured (at 37°C in 5% CO2 in medium) PBMC were used as effector cells. The rationale of using overnight cultured PBMC in addition to freshly isolated PBMC as effector cells was that in subsequent experiments, overnight cultured PBMC were used as proper controls for cytokine activation of NK activity. The mean NK activity of freshly isolated PBMC from KA patients (n = 6) was significantly less than that of the normal controls (n = 4). Of six patients tested, PBMC of two had NK activity within the lower range of normal values (Table  1) . Mean NK activity of overnight cultured PBMC from KA patients (n = 7) was also significantly less than that of normal controls (n = 7 (6) , in which NK activity was studied in patients with visceral leishmaniasis. They studied six children with visceral leishmaniasis and documented impairment of NK activity in 50% of these children. In our study with a total of 24 Indian KA patients, NK activity was measured in cells from 13 patients by 51Cr release assays and impairment was observed in 76.9% of the patients.
To determine whether recombinant human cytokines, which are known to activate NK cells, were able to restore depressed NK activity of KA patients, PBMC were prein- In vitro effect of rhIL-2 on NK activity of normal individuals and Indian KA patients. PBMC were preincubated in medium alone or in the presence of the indicated concentrations of rhIL-2 for 18 h at 370C in 5% CO2, washed twice, and tested for cytotoxicity against K562 cells in 4-h 5tCr release assays. The data represent the mean + SD of five experiments for both KA patients and normal individuals. The following patients and normal controls were included in the study: KA patient no. 14 (male, 20 years old) and patients 1, 3, 4, and 6 of Table 1 ; normal control no. 11 (male, 25 years old) and controls 3 to 6 of Table 1. cubated with various concentrations (200 and 20 U/ml) of recombinant human alpha interferon (rhIFN-a), rhIFN--y, recombinant human interleukin 2 (rhIL-2), or medium alone for 18 h, washed twice, and tested for NK activity. rhIFN-a (antiviral activity of 5.2 x 106 U/ml) and rhIFN-y (antiviral activity of 2.7 x 107 U/ml) were kindly donated by Hoffmann-La Roche Inc., Nutley, N.J. rhIL-2 (specific activity of 2.5 x 106 U/mg) was purchased from Genzyme Corp., Boston, Mass. NK activity of all normal individuals tested (n = 3) was increased significantly when their PBMC were preincubated with rhIFN-a. In contrast, NK activity of none of the KA patients tested (n = 3) was increased at all with these concentrations of rhIFN-oa (data not shown). Enhancement of NK activity was also obtained with PBMC from normal individuals (n = 4) after preincubation with rhIFN-,y (200 and 20 U/ml), although differences were not statistically significant at any of the three E/T ratios tested (data not shown). However, NK activity of KA patients (n = 5) was not appreciably increased by pretreatment of their PBMC with either 20 or 200 U of rhIFN--y per ml (data not shown). In contrast to our results, Harms et al. (6) reported that rhIFN--y at even lower concentrations (0.1 to 10 U/ml) augmented NK activity in visceral leishmaniasis patients when rhIFN--y was added directly to the assay mixtures. Differences in NK-enhancing abilities of IFN--y in different studies may be attributable to different preparations of IFN--y and assay conditions. In our study, IFN--y was used for preincubation with PBMC instead of being added directly to the assay mixtures to avoid any possible effect(s) of IFN--y on the susceptibility of target cells. After pre-exposure, rhIL-2, unlike rhIFN-a or rhIFN--y, enhanced NK activity in four of five KA patients. Characteristics of these patients are given in the legend to Fig. 1 . NK activity of one patient (patient 2, Table 1 ) did not respond to IL-2 activation. With 200 U of rhIL-2 per ml, statistically significant enhancement was achieved in the remaining four patients tested at EST ratios of 50:1 (P < 0.005), 25:1 (P < 0.02), and 12.5:1 (P < 0.03) (Fig. 1) . With 20 U/ml, enhancement was not statistically significant at any of the three E/T ratios tested. As expected, NK activity in all normal individuals (n = 5) was significantly enhanced by rhIL-2. With 200 U/ml, significant enhancement was noticed at E/T ratios of 50:1 (P < 0.008), 25:1 (P < 0.02), and 12.5:1 (P < 0.03). With a lower concentration of rhIL-2 (20 U/ml), NK activity was also increased at all E/T ratios. However, the differences were not significant (Fig. 1) . The possibility that the observed NK-enhancing effect of IL-2 was due to the direct effect of IL-2 on target cells was ruled out by additional controls. PBMC from both KA patients and normal individuals were first heat killed (100°C for 30 min) before preincubation with rhIL-2. No killing was detected with these PBMC. Moreover, addition of 200 U of rhIL-2 per ml to the target-only cultures had no effect on the spontaneous release. Similar results were obtained in previous studies with acquired immunodeficiency syndrome patients. NK activity in such patients against cytomegalovirus-infected fibroblasts could be stimulated in vitro by IL-2 but not by IFN-j (14) .
Our previous experiments suggested impairment of NK activity in KA patients. We therefore determined whether this defect is attributable to the reduced number of NK cells in the peripheral blood. The percentage of NK cells was quantitated by indirect immunofluorescence staining as described previously (2) with anti-CD16 monoclonal antibody (MAb) 3G8, anti-CD46 MAb OKM1, anti-CD56 MAb B159.1, and anti-CD57 MAb HNK-1. Anti-CD16 (low-affinity Fc receptor on polymorphonuclear neutrophils and NK cells) MAb 3G8 (5) was kindly provided by J. Unkeless, Mount Sinai School of Medicine, New York, N.Y. MAb B159.1 (anti-CD56) was kindly provided by G. Trinchieri, Wistar Institute, Philadelphia, Pa. Antibodies OKM1 (anti-CD46 antigen on monocytes and granulocytes [7] ) and HNK-1 (anti-CD57), which recognizes a homogeneous population of human blood lymphocytes having both NK and antibody-dependent killer cell functions (1), were produced from cells purchased from the American Type Culture Collection, Rockville, Md. Cells from six KA patients and six normal controls were analyzed by indirect immunofluorescence staining (Table 2) . Although most of the KA patients were leukopenic (data not shown), the percentage of their peripheral blood NK cells was absolutely normal (Table 2) . These results are in agreement with that of Sciotto et al. (15) , who also noticed no significant variation in the percentage of HNK1-positive cells in the peripheral blood of visceral leishmaniasis patients. However, leukopenia is not the cause of the depressed NK activity observed in KA patients as equal numbers of PBMC for both normal controls and KA patients were used for NK assays.
There are several possible explanations for the observed impairment of NK activity in KA patients despite their having normal numbers of NK cells. NK cells from KA patients may have defects in target recognition which may in turn affect E/T conjugate formation. NK cells from KA patients may also lack the ability to lyse the bound targets. Single-cell assays were performed with PBMC from five KA patients and six normal individuals as described previously (4) to address these questions. Briefly, PBMC and K562 targets were equilibrated separately at 30°C at a concentration of 2 x 106/ml. PBMC (100 ,ul) and targets (200 pl) were then added together (EST ratio, 1:2) and incubated at 30°C for 5 min. These cells were then centrifuged at 200 x g for 5 min. The supernatants were gently poured off. RPMI 1640 medium with 10% fetal bovine serum (50 pl) was added to the pellet and the pellet was resuspended. Molten agarose (50 pl, 1.33%, prepared in RPMI 1640; Bio-Rad Laboratories, Richmond, Calif.), kept at 39°C, was added directly to the resuspended pellet. The tube was gently shaken and quickly inverted onto an agarose-precoated glass slide. The agarose mixture was gently and evenly spread over the entire slide, allowed to gel, submerged in RPMI 1640 with 10% fetal bovine serum, and then incubated for 18 h at 37°C in 5% CO2 in a humidified incubator. After incubation, the slides were stained for 5 min in 0.2% trypan blue, washed with 0.3% formalin in phosphate-buffered saline, and read microscopically. The percentage of lymphocytes bound to targets was determined by the following formula: % lymphocyte bound to targets = 100 x (number of conjugates/total number of lymphocytes [free and bound to targets]). The percentage of lymphocyte-bound targets killed was calculated by the following formula: % lymphocyte-bound targets killed = 100 x 'P < 0.02 versus PBMC from normal controls preincubated with medium.
(number of dead targets in conjugates/total number of conjugates). The effectors were classified as unbound, bound to viable targets, or bound to dead targets. The unbound target viability at the end of 18-h assays was never less than 92%. Data presented in Table 3 indicate that both target recognition and lytic ability of bound targets were significantly deficient in KA patients. We also addressed the question of whether IL-2-induced reconstitution of NK lytic activity of KA patients, as determined by 51Cr release assays (Fig. 1) , affected conjugate formation and/or lytic ability. As shown in Table 3 , pretreatment of PBMC with 200 U of rhIL-2 per ml for 18 h significantly enhanced conjugate formation and lytic ability in both normal individuals and KA patients. In similar studies, deficient NK lytic function resulting from Chediak-Higashi disease (11) in humans and the beige mutation in mice (13) was reportedly due to the inability of NK cells to lyse the bound targets.
In conclusion, our data indicate that although KA patients have normal numbers of NK cells in their peripheral blood, this cell subset is deficient in both target binding and bound-target killing and unresponsive to rhIFN-a and rhIFN--y. The decreased NK activity of KA patients may be improved, at least in vitro, by preincubation of PBMC with IL-2 which enhances both conjugate formation and lytic ability. NK cells appear to play a relatively weak role in resolution of experimental Leishmania infection in the liver (12, 16) . Also, NK cells do not exert detectable antileishmanial activity in nude mice and mice with severe combined immunodeficiency (12) . However, a role for NK cells in host recovery from visceral leishmaniasis, particularly in control of infection in the spleen, in the mouse model was suggested (8, 10) . Deficient NK activity in KA may therefore affect the recovery process and contribute to susceptibility to secondary infections, accounting for much of the mortality occurring in visceral leishmaniasis.
